Jubilant DraxImage is dedicated to providing radiopharmaceuticals for the diagnosis and treatment of a variety of diseases. We invite you to learn more about these areas and how our products are used by healthcare professionals to care for their patients.
TIME is a program developed to improve patients’ understanding of thyroid cancer treatment options and to help guide your patients’ decision making.
To learn more about these resources or to order copies, please email TIME@jdi.jubl.com
Physician/Patient Flip Chart
In-office discussion aid that helps facilitate conversations with patients, from initial diagnosis through treatment and long-term monitoring
Informed Consent for Low-Risk Thyroid Cancer
An article by M. Sara Rosenthal and colleagues, housed in a reprint carrier that provides an overview of the topic and how to put it into practice
Thyroid Cancer Treatment Roadmap
At-a-glance infographic explaining thyroid cancer diagnosis and treatment options
The following materials have been developed for patients:
Thyroid Cancer Treatment Road map
Download An at-a-glance infographic explaining thyroid cancer diagnosis and treatment options.
Radioactive Iodine (Iodine-131): What to Expect
Download A guide for patients on considerations before, during, and after treatment.
Radioactive Iodine (Iodine-131): Fact vs Fiction
Download A useful list dispelling common misconceptions patients may have about Iodine-131.
Informed Consent Guide
Download A review of important points you should consider before making treatment decisions with their doctors.
Radioactive Iodine (Iodine-131) Video
Highlights how and why radioactive iodine (Iodine-131) is used. Includes commentary from the perspective of physicians, and patients who have received I-131 therapy.
For thyroid cancer support groups, educational events, videos, education materials, and more patients’ resources, visit: